Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and levels of C-reactive protein (CRP) are all examples of biomarkers that have been demonstrated numerous times to correlate with survival and immunotherapy efficacy in a variety of malignancies [12,13,14]. Here, CRP is linked to cancer.